VIONA PHARMACEUTICALS INC FDA Record
- No warning letters matched by name
VIONA PHARMACEUTICALS INC has 8 FDA recalls, 0 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "VIONA PHARMACEUTICALS INC" is on file.
- Latest recall
- D-0016-2026 · Class II · Oct 6, 2025
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 8 | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 0 | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
VIONA PHARMACEUTICALS INC: FDA recall records per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 2 | 0 |
| 2024 | 0 | 0 | 0 | 4 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 2 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2017 | 0 | 0 | 0 | 0 | 0 |
Reviewing VIONA PHARMACEUTICALS INC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check VIONA PHARMACEUTICALS INC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0016-2026 | Class II | Tavaborole Topical solution 5%, 10 mL bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd… | Oct 6, 2025 |
| D-0595-2025 | Class II | Tavaborole Topical Solution 5%, 10 mL per glass bottle, Rx Only, For Topical Use Only, Manufactured… | Aug 12, 2025 |
| D-0171-2025 | Class II | Dapsone Gel 7.5%, 60 g, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahemedabad, India… | Dec 10, 2024 |
| D-0172-2025 | Class II | Dapsone Gel 7.5%, 90 g, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India… | Dec 10, 2024 |
| D-0038-2025 | Class II | Dapsone Gel 7.5%, 60 gram pump, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India… | Oct 29, 2024 |
| D-0011-2025 | Class II | Dapsone Gel 7.5%, 60 gram pump, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India… | Sep 24, 2024 |
| D-0392-2022 | Class II | Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, 100 count HDPE bottles NDC#… | Dec 27, 2021 |
| D-0640-2021 | Class II | Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, 100 Tablets, Rx only, Manufactured by… | Jun 1, 2021 |
VIONA PHARMACEUTICALS INC and the FDA: common questions
Has VIONA PHARMACEUTICALS INC received an FDA warning letter?
No FDA warning letter addressed to the name "VIONA PHARMACEUTICALS INC" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has VIONA PHARMACEUTICALS INC received an FDA Form 483?
FDA has not published a Form 483 for "VIONA PHARMACEUTICALS INC" in its reading room. FDA publishes some Form 483s, not all of them.
Has VIONA PHARMACEUTICALS INC had an FDA recall?
Yes. VIONA PHARMACEUTICALS INC has 8 FDA recalls on record. The most recent started Oct 6, 2025.
Need more than this page shows? Ask about VIONA PHARMACEUTICALS INC in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.